Inhibitors of 3beta-Hydroxysteroid Dehydrogenase and Metabolic and Enzymatic Characterization of the Cholesterol Metabolizing Intracellular Growth Operon of Mycobacterium tuberculosis
Year: 2012
Type: dissertation
Abstract: New drugs with novel mechanisms of action are required to meet the severe threat to human health posed by the emergence of multidrug and extensively drug resistant strains of Mycobacterium tuberculosis (M.tuberculosis).The cholesterol metabolism pathway in M. tuberculosis is a potential source of energy as well as secondary metabolite production that is important for survival of M. tuberculosis in the host macrophage.Oxidation and isomerization of 3β--hydroxysterols to 4--en--3--ones by M. tuberculosis 3β-hydroxysteroid dehydrogenase (3β--HSD) is required for sterol metabolism, and inhibitors of 3β--HSD are important for targeting the cholesterol metabolic pathway.In this work, we evaluated a series of azasteroids for inhibition of 3β--HSD.Our structure-activity studies indicate that the 6--aza version of cholesterol is the best and tightest binding competitive inhibitor (Ki = 100 nM) of the steroid substrate and are consistent with cholesterol being the preferred substrate of M. tuberculosis 3β--HSD.The intracellular growth (igr) operon is required for in vitro growth using cholesterol as a sole carbon source.The function of igr operon and its role in cholesterol metabolism is yet to be established.Here we describe the biosynthetic preparation of isotopically labeled 13 C--[1,7,15,22,26]--cholesterol and employ it as a tool to investigate the iv cholesterol--derived metabolite profile of the M. tuberculosis H37Rv Δigr mutant strain by high resolution LC/MS.Culture supernatants from the Δigr mutant accumulate a cholesterol--derived metabolite not observed in H37Rv wild type or complemented strains.Multidimensional NMR and mass spectral analysis revealed the structure of this cholesterol--derived catabolite to be a late stage metabolic product: methyl 1β--(2'-- propanoate)--3aα--H--4α(3'--propanoic acid)--7aβ--methylhexahydro--5--indanone.The computationally annotated functions of the six genes of the igr operon are a lipid transfer protein (ltp2/Rv3540c), two (R)--specific enoyl--CoA hydratases (Rv3541c and), two acyl--CoA dehydrogenases (fadE29/Rv3543c and fadE28/Rv3544c), and a cytochrome P450 (cyp125/Rv3545c).Heterologous expression in E. coli demonstrated that FadE28 forms a heteromeric complex with FadE29, and that likewise, Rv3542c forms a heteromeric complex with Rv3541c.Biophysical characterization of each complex established they form novel α2β2 heterotetramers.Using synthetic substrates analogous to the metabolite identified in M. tuberculosis H37Rv Δigr mutant strain, we verified the catalytic activity of the purified, recombinant FadE28--FadE29 and Rv3541c--Rv3542c protein complexes to be dehydrogenation and hydration of the 2'--propanoate--CoA side chain.We conclude the igr operon is required for degradation of the 2'--propanoate side chain fragment during metabolism of cholesterol by M. tuberculosis.Chapter 3 -Experimental Methods 85 I. Materials 87 vi II.General Methods 87 III.Instrumentation 88 IV.Buffers 88 V. Expression plasmid construction and plasmid table 89 VI.Expression and protein purification 90 VII.In--gel tryptic digestion and MALDI--TOF mass fingerprinting 94 VIII.Azasteroids 94 IX. 3β--HSD assay 94 X. Isotopic labeling of LDL--cholesterol 95 XI.Metabolic labeling of M. tuberculosis 96 XII.Growth of M. tuberculosis in the presence of free cholesterol 96 XIII.Biochemical analysis of LDL--derived [ 14 C]--lipids 97 XIV. Biochemical extraction and analysis of cholesterol--derived bacterial lipid metabolite 97 XV.Purification and characterization of cholesterol--derived metabolite 1 98 XVI.FadE28--FadE29 substrate synthesis 98 XVII.Dehydrogenase assay 100 XVIII.Hydratase assay 100 XIX.Identification and quantification of flavin cofactor 100 XX.Analytical gel--filtration 100 XXI.Analytical ultracentrifugation sedimentation equilibrium 101 XXII.LC/UV/MS of intact protein complexes 101 Chapter 4 --Conclusions and Future Perspectives 103 I. 6--azasteroid inhibitors of M. tuberculosis cholesterol metabolism 104 II.Cholesterol--derived metabolite profiling with [1,7,15,22,26--13 C]--cholesterol 105 vii III.Investigating the FadE proteome of M. tuberculosis 107 IV. Studies of heteromeric (R)--hydratases 108V. Final conclusions 110Chapter 5 --References 111
Author: Suzanne T. Thomas
Institution: Stony Brook University
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W2520326912
